New data question treatment for oxaliplatin neurotoxicity.
Wolf
Sherry L
SL
D000970:Antineoplastic Agents / Q000009:adverse effects*; D002118:Calcium / Q000627:therapeutic use; D019317:Evidence-Based Medicine / Q000592:standards*; D006801:Humans; D008274:Magnesium / Q000627:therapeutic use; D020258:Neurotoxicity Syndromes / Q000209:etiology / Q000628:therapy; D009944:Organoplatinum Compounds / Q000009:adverse effects*; D000077150:Oxaliplatin; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced / Q000628:therapy; D016032:Randomized Controlled Trials as Topic; D012107:Research Design / Q000592:standards
D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D008274:Magnesium; D002118:Calcium